at Pfizer, Inc in Bentonville, Arkansas, United States
Successful product access is fundamental to the achievement of Pfizer's commercial objectives in the evolving, complex pharmaceutical payer environment, which must begin in early development. The Rare Disease (RD) and Immunology and Inflammation (I&I) business units within Pfizer have a robust pipeline of products in many therapeutic areas: hematology, cardiology, neuromuscular, metabolic and endocrine (RD) and medical dermatology, rheumatology, and gastroenterology (GI; I&I).
The Integrated Team Leader, Pipeline/Business Development, I&I/Rare Disease, is responsible for development and inclusion of high-quality evidence generation plans and market access strategies into the internal and external development assessments for national-level public payers and private commercial insurers.
This ILT will function with a One PHI mindset and will lead a team of health economics and outcomes research (HEOR) scientists and market access and pricing strategists. She/he will join the I&I PHI LT and RD PHI LT to ensure there is a single and coordinated view on strategy and delivery for PHI, and will collaborate seamlessly with the PHI Centers of Excellence such as RWE CoE, Healthcare Innovation Center, and others. The team lead will become a strategic partner to research, development, regulatory, commercial, medical, prioritized country teams and any alliance partners.
The ITL must have a global business-wide perspective and should adopt a leadership position on strategic questions with respect to the value, access and outcomes required of assets in development and be the "voice of the payer" to internal stakeholders. She/he needs to have a high degree of expertise and employ a patient and payer-centric mindset to work closely in an aligned fashion with various partner and stakeholder groups and innovative approaches for RD and gene therapies in development. This will ensure there is a single and coordinated view on strategy to provide timely delivery of PHI outputs to inform key business decisions. Lastly, the ITL must be able to design, develop and implement an integrated approach to all aspects of the payer value proposition from early development through phase III and across geographies (such as US, EU, Asia) for RD & I&I TAs described above.
Lead Team: Lead Pipeline/BD I&I and RD franchise comprised of HEOR scientists, PCOA scientists and market access strategists
Execute projects as per Operating Plans or newly identified priorities and manage pipeline budget for those projects
Lead and oversee HEOR strategy development and implementation to support brand strategies and product positioning
Oversees and approves evidence generation activities, such as: RWD studies of comparative effectiveness and cost; design and implementation of clinical trials with HEOR components; and early economic models, aligned with the overall product strategy
Lead development of early economic modeling for population selection and early pricing
Able to influence and shape the life cycle management program utilizing individual depth of knowledge and experience in value evidence generation and reimbursement
Represent Pfizer's interests in high level interactions with influential bodies (affiliates, international health administration bodies, advocacy groups, specialty associations, etc.)
Provide leadership and mentorship development including subject matter expertise as needed
Provide relevant input into selection of patient population and comparators within clinical trials to enable demonstration of robust incremental clinical value over standard of care that can facilitate optimal patient access
Approve the selection, related analyses, interpretation and communication of Patient Reported Outcomes (PRO) measures as appropriate for assigned clinical trials, registries, and prospective real world studies
Enterprise Leadership & Strategic Partnership: Become an leading member of the PHI I&I/RD LTs and a strategic partner to WRD, GPD, Commercial Marketing, Medical, prioritized countries and Regulatory; effectively liaise with PHI's Centers of Excellence
Advance functional excellence for Market Access and Health Economics and Outcomes Research
Deliver clear recommendations for the overall access and payer strategy, pricing and reimbursement, evidence... For full info follow application link.
EEO & Employment Eligibility:
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.